Defining human mesenchymal stem cell efficacy in vivo

Allogeneic human mesenchymal stem cells (hMSCs) can suppress graft versus host disease (GvHD) and have profound anti-inflammatory and regenerative capacity in stroke, infarct, spinal cord injury, meniscus regeneration, tendinitis, acute renal failure, and heart disease in human and animal models of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonfield, Tracey L, Nolan (Koloze), Mary T, Lennon, Donald P, Caplan, Arnold I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987779/
https://www.ncbi.nlm.nih.gov/pubmed/20974000
http://dx.doi.org/10.1186/1476-9255-7-51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987779/
https://www.ncbi.nlm.nih.gov/pubmed/20974000
http://dx.doi.org/10.1186/1476-9255-7-51

Ejemplares similares